Found: 18
Select item for more details and to access through your institution.
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
- Published in:
- Journal of NeuroVirology, 2007, v. 13, n. 6, p. 549, doi. 10.1080/13550280701591526
- By:
- Publication type:
- Article
Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
- Published in:
- Journal of Biomedical Science, 2018, v. 25, p. 1, doi. 10.1186/s12929-018-0413-9
- By:
- Publication type:
- Article
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.1049065
- By:
- Publication type:
- Article
Using MRI cell tracking to monitor immune cell recruitment in response to a peptide‐based cancer vaccine.
- Published in:
- Magnetic Resonance in Medicine, 2018, v. 80, n. 1, p. 304, doi. 10.1002/mrm.27018
- By:
- Publication type:
- Article
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillusanthracis spore inhalation challenge.
- Published in:
- NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0102-z
- By:
- Publication type:
- Article
Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008603
- By:
- Publication type:
- Article
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00264
- By:
- Publication type:
- Article
ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 6, p. 1148, doi. 10.1038/mt.2011.301
- By:
- Publication type:
- Article
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82108-4
- By:
- Publication type:
- Article
The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/1179554921993069
- By:
- Publication type:
- Article
The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/1179554921993069
- By:
- Publication type:
- Article
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 156, doi. 10.1186/1479-5876-10-156
- By:
- Publication type:
- Article
Targeting Tumor Vasculature With an Oncolytic Virus.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 5, p. 886, doi. 10.1038/mt.2011.26
- By:
- Publication type:
- Article
Potent Oncolytic Activity of Raccoonpox Virus in the Absence of Natural Pathogenicity.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 5, p. 896, doi. 10.1038/mt.2010.14
- By:
- Publication type:
- Article
Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 1, p. 52, doi. 10.1038/sj.mt.6300348
- By:
- Publication type:
- Article
Immunopathogenesis of poxvirus infections: forecasting the impending storm.
- Published in:
- Immunology & Cell Biology, 2007, v. 85, n. 2, p. 93, doi. 10.1038/sj.icb.7100033
- By:
- Publication type:
- Article
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0180073
- By:
- Publication type:
- Article